Why the study?
What is the test-retest reliability of peripheral arterial tonometry for assessing endothelial dysfunction in adults with metabolic syndrome?
What is the test-retest reliability of peripheral arterial tonometry for assessing endothelial dysfunction in adults with metabolic syndrome?
Peripheral arterial tonometry demonstrates robust test-retest reliability for assessing endothelial dysfunction in adults with metabolic syndrome, requiring relatively small sample sizes for future clinical trials.
Answers are grounded in this paper and cite their sources.
May reduce sample sizes needed for endothelial function trials in metabolic syndrome; leaves open prognostic or therapeutic utility.
Endothelial dysfunction is an important contributor to atherosclerosis and cardiovascular disease. However, routine assessment via angiography or flow-mediated dilation is difficult due to technical limitations. Peripheral arterial tonometry (PAT) is a promising alternative method for non-invasive assessment of endothelial dysfunction. This study assessed the test-retest reliability of PAT in adults with the metabolic syndrome (n = 20) and provides sample size and power estimates for study design. Participants completed five PAT tests each separated by 1 week. The PAT-derived reactive hyperaemia index (RHI) showed robust repeatability (intra-class correlation = 0.74). A parallel-arm study powered at 0.90 would require 22 participants to detect an absolute change in RHI of 0.40 units (equal to ~25% change in this sample), whereas a crossover study would require 12 participants. In conclusion, we have demonstrated that PAT can be used to assess endothelial dysfunction in adults with the metabolic syndrome as reliably as in healthy samples.
No takes yet. Share an insight, caveat, or question.
Sauder et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: